CLINICAL TRIALS PROFILE FOR NICODERM CQ
✉ Email this page to a colleague
All Clinical Trials for NICODERM CQ
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00086411 ↗ | Comparing Smoking Treatment Programs for Lighter Smokers - 1 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 2003-09-01 | The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two levels of counseling. It was hypothesized that the higher level of counseling would have the highest rates of treatment completion and highest rates of abstinence. |
| NCT00086411 ↗ | Comparing Smoking Treatment Programs for Lighter Smokers - 1 | Completed | Peter Gariti | Phase 2 | 2003-09-01 | The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two levels of counseling. It was hypothesized that the higher level of counseling would have the highest rates of treatment completion and highest rates of abstinence. |
| NCT00086411 ↗ | Comparing Smoking Treatment Programs for Lighter Smokers - 1 | Completed | University of Pennsylvania | Phase 2 | 2003-09-01 | The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two levels of counseling. It was hypothesized that the higher level of counseling would have the highest rates of treatment completion and highest rates of abstinence. |
| NCT00139516 ↗ | Chinese Community Smoking Cessation Project | Completed | National Heart, Lung, and Blood Institute (NHLBI) | N/A | 2001-09-01 | The study has two objectives/aims: Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months |
| NCT00139516 ↗ | Chinese Community Smoking Cessation Project | Completed | University of California, San Francisco | N/A | 2001-09-01 | The study has two objectives/aims: Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months |
| NCT00158171 ↗ | Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 2002-04-01 | Currently one in five high school students smokes. Smoking can harm adolescents well before they reach adulthood by causing a number of immediate, sometimes irreversible, health risks and problems. This study will compare the effectiveness of treatment with bupropion, a nicotine patch, or nicotine gum in supporting the reduction of smoking in adolescent smokers. |
| NCT00218296 ↗ | Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use | Completed | University of Minnesota | Phase 2 | 2006-11-01 | Smokeless tobacco (ST), which includes both chewing tobacco and snuff, has health risks associated with its use. While treatment programs that focus on stopping tobacco use may be effective, past research has shown that interventions that specifically focus on reducing tobacco use may be equally effective and may motivate individuals to eventually quit using tobacco. This study will compare the effectiveness of a ST reduction treatment program versus a usual tobacco cessation treatment program (immediate cessation) for reducing tobacco use in ST users. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NICODERM CQ
Condition Name
Clinical Trial Locations for NICODERM CQ
Trials by Country
Clinical Trial Progress for NICODERM CQ
Clinical Trial Phase
Clinical Trial Sponsors for NICODERM CQ
Sponsor Name
